Gaya APA
Efficacy and safety of evolocumab (AMG 145), a fully humanmonoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials. ().
[s.i.]:
.
Gaya MLA
Efficacy and safety of evolocumab (AMG 145), a fully humanmonoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials.
.
[s.i.]:
,
.
Text.